FDA Reports Possible Link Between COVID-19 Vaccines and Child Deaths, Enhances Oversight Measures
An internal memo from the FDA suggests that at least 10 children may have died as a result of COVID-19 vaccines, with myocarditis identified as a possible cause, according to a report from the New York Times.
The memo, authored by Dr. Vinay Prasad, the agency's chief medical and scientific officer, did not specify the ages of the deceased children or their pre-existing health conditions, nor did it identify the vaccine manufacturers involved.
Dr. Prasad characterized these findings as a "deep revelation" and announced plans to enhance oversight of vaccines, including the necessity for randomized studies across all demographics.
This development occurs amid a significant shift in U.S. vaccine policy, as Health Secretary Robert Kennedy Jr. has revised official recommendations to restrict vaccine access primarily to high-risk groups, specifically individuals aged 65 and older and those with underlying health conditions.
Kennedy, known for his skepticism regarding vaccines prior to his appointment, has previously linked vaccines to autism and is advocating for changes in national vaccination strategies.
Additionally, the CDC vaccine committee is scheduled to convene in the coming days to address these emerging concerns.
Dr. Vinay Prasad, who resumed his role at the FDA last September, is recognized as a vocal critic of mandatory COVID vaccinations and mask mandates in the U.S. He provides guidance to the commissioner and senior officials on significant medical and scientific issues.
The U.S. Department of Health and Human Services, which oversees the FDA, did not respond to a request for comment from Reuters regarding this report at the time of publication.
